COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19
Background: Patients with coronavirus infectious disease 2019 (COVID-19) and gastrointestinal symptoms showed increased values of fecal calprotectin (FC). Additionally, bowel abnormalities were a common finding during abdominal imaging of individuals with COVID-19 despite being asymptomatic. The cur...
Main Authors: | Mauro Giuffrè, Stefano Di Bella, Gianluca Sambataro, Verena Zerbato, Marco Cavallaro, Alessandro Agostino Occhipinti, Andrea Palermo, Anna Crescenzi, Fabio Monica, Roberto Luzzati, Lory Saveria Crocè |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Tropical Medicine and Infectious Disease |
Subjects: | |
Online Access: | https://www.mdpi.com/2414-6366/5/3/147 |
Similar Items
-
Fecal calprotectin concentration in neonatal necrotizing enterocolitis
by: Jung Min Yoon, et al.
Published: (2014-08-01) -
Faecal calprotectin in COVID-19 patients with intestinal symptoms
by: Walid Ellakany, et al.
Published: (2022-03-01) -
Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients
by: Deasy Natalia Adriana, et al.
Published: (2022-08-01) -
Fecal Calprotectin Level in Neonates with Necrotizing Enterocolitis
by: Maha Abdelkader, et al.
Published: (2019-09-01) -
Elevated level of circulating calprotectin correlates with severity and high mortality in patients with COVID‐19
by: Haoran Zhang, et al.
Published: (2024-03-01)